| Literature DB >> 30568973 |
Maura Manion1, Thomas Uldrick2, Mark N Polizzotto2, Virginia Sheikh1, Gregg Roby1, Kathryn Lurain2, Dorinda Metzger1, JoAnn M Mican1, Alice Pau1, Andrea Lisco1, Elizabeth Laidlaw1, Dima A Hammoud3, Denise Whitby4, Robert Yarchoan2, Irini Sereti1.
Abstract
Corticosteroid use was associated with development of Kaposi's sarcoma or multicentric Castleman disease in 3 patients with mycobacterial immune reconstitution inflammatory syndrome (IRIS) treated with corticosteroids. Monitoring for development of Kaposi's sarcoma and alternative treatment may be beneficial for patients with IRIS, especially in the presence of preexisting co-infection with Kaposi's sarcoma-associated herpesvirus.Entities:
Keywords: KSHV; TB-IRIS
Year: 2018 PMID： 30568973 PMCID： PMC6182308 DOI： 10.1093/ofid/ofy217
Source DB: PubMed Journal: Open Forum Infect Dis ISSN： 2328-8957 Impact factor: 3.835